English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Isagro sales up 22% in Q3 2014qrcode

Nov. 17, 2014

Favorites Print
Forward
Nov. 17, 2014

Isagro’s sales posted a 22.3% increase to €29.4 million in the third quarter ended Sep 30, 2014. For the first nine months of 2014, the sales increased by 20.8% to €102.3 million,which have been characterized by the recovery of sales versus 2013 (a year which was negatively affected by the "carried-over” effect of 2012 drought) and by the start of the commercial cooperation with the partner Gowan in USA and in Italy; such elements more than offset a weakening of Group’s sales in Brazil and lower sales of Orthosulfamuron and Valiphenalate (the latter two molecules divested in 2013).

Isagro sales results (€000)
Q3 ended Sep. 30
Q3 2014
Q3 2013
Change %
Nine-month
   2014
Nine-month
   2013
Change %
Sales
29,369
24,020
+22.3
102,303
84,717
+20.8
EBITDA*
(loss)
798
(641)
-
7,698
905
751
EBIT** (loss)
(1,347)
(2,975)
-
1,220
(6,289)
-
* earnings before interest and tax depreciation and amortisation
** earnings before interest, tax

Outlook

Isagro’s sales in the fourth quarter are expected to be lower compared to the same period of last year, due to reduced year-end purchases by the distribution systems in Brazil (due to consumption of existing stock and to a weakening of market conditions for Isagro’s products) and in Italy (to limit year-end stocks).
 

0/1200

More from AgroNewsChange

Hot Topic More

Subscribe Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe AgroNews Daily Alert to send news related to your mailbox